Options for the management of mucosal candidiasis in patients with AIDS and HIV infection.
about
Screening of Tanzanian medicinal plants for anti-Candida activity.The use of fluconazole and itraconazole in the treatment of Candida albicans infections: a review.Safety, pharmacokinetics, and pharmacodynamics of cyclodextrin itraconazole in pediatric patients with oropharyngeal candidiasisEmerging fungal infections among children: A review on its clinical manifestations, diagnosis, and prevention.Fluconazole for the treatment of candidiasis: 15 years experience.In vivo biocompatibility and in vitro efficacy of antimicrobial gendine-coated central catheters.Candida glabrata Binding to Candida albicans Hyphae Enables Its Development in Oropharyngeal Candidiasis.Role of posaconazole in the management of oropharyngeal and esophageal candidiasisCandida glabrata: an emerging oral opportunistic pathogen.Novel antiseptic urinary catheters for prevention of urinary tract infections: correlation of in vivo and in vitro test results.Development of Gendine-Coated Cannula for Continuous Subcutaneous Insulin Infusion for Extended Use.Activities of an intravenous formulation of itraconazole in experimental disseminated Aspergillus, Candida, and Cryptococcus infections.Variation in genes of β-glucan recognition pathway and susceptibility to opportunistic infections in HIV-positive patients.Cytotoxic and cytokine-inducing properties of Candida glabrata in single and mixed oral infection models.Posaconazole for the management of mucosal candidiasis.A rapid method of impregnating endotracheal tubes and urinary catheters with gendine: a novel antiseptic agent.Development of an antifungal denture adhesive film for oral candidiasis utilizing hot melt extrusion technology.Production and characterization of hot-melt extruded films containing clotrimazole.A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients.The Interface between Fungal Biofilms and Innate Immunity.Relative abundance of Candida albicans and Candida glabrata in in vitro co-culture biofilms impacts biofilm structure and formation.Comparative Proteomic Analysis of Candida albicans and Candida glabrata
P2860
Q33237953-2DD68EE6-B0FE-4DA4-AAA4-966448591CF5Q33788619-537F6062-DBB5-4D71-BAF1-3F19F77F61EAQ34111158-A945F056-F622-4C7E-B024-F3C0DA4761B2Q34373864-BC87C69A-BD09-40D4-BCC0-5BD632470989Q35917407-96B2B8DA-B78D-48E1-9B44-9846EBFF0F42Q35960782-D8F36333-BD4A-4DEA-94A5-77EAD47BB5EEQ35974301-6217C8CA-634C-4C81-B112-E2988B1EC7E9Q36642964-9F682244-B895-449E-A6CF-857508DABAD7Q36741765-18BEF897-288A-408B-A609-B51D7CBF7598Q37450736-F68FF036-220D-4648-978C-7320A5F50CF5Q38879038-F39D7C93-5FE4-4F26-856B-103C49BC8372Q39537321-4E2EA114-DA82-401B-909E-E932544B5BF5Q39699269-18A5BF91-7EF4-44F8-8DED-6A9B12514E96Q40170003-5B9D37CA-EE3D-4F07-9026-09DA6F03B100Q40188971-65620599-3E73-4EC7-B173-524845B8DC93Q40485856-33151921-1E0B-4E3B-B443-DD7AFD76DBCBQ42276006-FE9E7FC0-B88A-4D86-A4E7-B41A42ABB3D0Q44541502-F91395DB-86C9-44E8-B0B3-CCA4356796F5Q45097002-AA378D0E-CF5B-4F63-9792-08E23C72385CQ49203638-DD1F2960-8BB1-4C72-88BA-9BEF9E0154F0Q50050075-4F1F26DF-130C-402B-9B60-35095E564FCEQ58482730-42350C13-8A06-49E9-B516-633E8A4F451E
P2860
Options for the management of mucosal candidiasis in patients with AIDS and HIV infection.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Options for the management of ...... s with AIDS and HIV infection.
@en
type
label
Options for the management of ...... s with AIDS and HIV infection.
@en
prefLabel
Options for the management of ...... s with AIDS and HIV infection.
@en
P2860
P1433
P1476
Options for the management of ...... s with AIDS and HIV infection.
@en
P2093
Vazquez JA
P2860
P356
10.1592/PHCO.19.1.76.30509
P407
P577
1999-01-01T00:00:00Z